ICH GCP - Clinical Trials Registry

Example: Heart Attack

Total 335 results

NCT01155960

Completed

Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fed Conditions

Conditions: Healthy
NCT01155947

Completed

Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fasting Conditions

Conditions: Healthy
NCT03314298

Completed

A Single Dose Trial to Evaluate the Pharmacokinetics of Testosterone and Anastrozole

Conditions: Mammographic Density
NCT03229499

Active, not recruiting

Pulmonary Hypertension and Anastrozole Trial

Conditions: Pulmonary Arterial Hypertension
NCT02140437

Withdrawn

Fulvestrant Combined Anastrozole Versus Anastrozole in Luminal A-like Postmenopausal ABC

Conditions: Carcinoma Breast Stage IV
NCT01972984

Completed

Feasibility Study of Presurgical Hormone Therapy (Anastrozole) in Breast Cancer Patients

Conditions: Breast Cancer
NCT02730923

Recruiting

Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA)

Conditions: Endometrial Carcinoma; Metastatic Carcinoma; Hormone Receptor Positive Tumor
NCT03264651

Completed

Enobosarm and Anastrozole in Pre-menopausal Women With High Mammographic Breast Density

Conditions: Mammographic Density
NCT00421447

Completed

Bone Geometry and Muscle Density Changes in Postmenopausal Women and Breast Cancer Patients Prescribed Anastrozole

Conditions: Breast Cancer
NCT00136695

Completed

Anastrozole Administration in Elderly Hypogonadal Men

Conditions: Hypogonadism
NCT04294225

Recruiting

Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer

Conditions: Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage IA Breast Cancer AJCC v8; Anatomic Stage IB Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage IIA Breast Cancer AJCC v8; Anatomic Stage IIB Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IIIA Breast Cancer AJCC v8; Anatomic Stage IIIB Breast Cancer AJCC v8; Anatomic Stage IIIC Breast Cancer AJCC v8; Early-Stage Breast Carcinoma; Invasive Breast Carcinoma; Prognostic Stage I Breast Cancer AJCC v8; Prognostic Stage IA Breast Cancer AJCC v8; Prognostic Stage IB Breast Cancer AJCC v8; Prognostic Stage II Breast Cancer AJCC v8; Prognostic Stage IIA Breast Cancer AJCC v8; Prognostic Stage IIB Breast Cancer AJCC v8; Prognostic Stage III Breast Cancer AJCC v8; Prognostic Stage IIIA Breast Cancer AJCC v8; Prognostic Stage IIIB Breast Cancer AJCC v8; Prognostic Stage IIIC Breast Cancer AJCC v8
NCT00543127

Terminated

Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole

Conditions: Breast Cancer
NCT01183390

Completed

Anastrozole 1 mg Tablets Under Fed Conditions

Conditions: Healthy
NCT02942355

Recruiting

Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer

Conditions: Female Breast Carcinoma
NCT00256217

Completed

Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women

Conditions: DCIS
NCT00244959

Completed

Anastrozole in Treating Postmenopausal Women With DCIS or Stage I-III Breast Cancer

Conditions: Breast Cancer
NCT04113863

Recruiting

ATRA Trial - ACTIVITY OF ATRA IN COMBINATION WITH ANASTROZOLE IN PRE-OPERATIVE PHASE OF OPERABLE HR-POSITIVE/HER2-NEGATIVE EARLY BREAST CANCER eBC ATRA TRIAL

Conditions: Breast Neoplasm Female
NCT01545336

Completed

Anastrozole in Patients With Pulmonary Arterial Hypertension

Conditions: Pulmonary Arterial Hypertension
NCT01016665

Completed

Anastrozole Reduced Proliferation and Progesterone Receptor Indexes in Short Term Hormone Therapy

Conditions: Breast Cancer
NCT01182181

Completed

Anastrozole 1 mg Tablets Under Fasting Conditions

Conditions: Healthy
NCT00481845

Terminated

Phase 2 Anastrozole and Vandetanib (ZD6474) in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer

Conditions: Breast Cancer
NCT00077025

Completed

Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast Cancer

Conditions: Breast Cancer
NCT00301457

Active, not recruiting

Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer

Conditions: Breast Cancer
NCT00638391

Completed

Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer

Conditions: Breast Cancer
NCT01155089

Completed

Bioequivalency Study of Anastrozole 1 mg Under Fed Conditions

Conditions: Breast Cancer
NCT01155102

Completed

Bioequivalency Study of Anastrozole 1 mg Under Fasted Conditions

Conditions: Breast Cancer
NCT00179517

Completed

Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo

Conditions: Seizure Disorder; Hypogonadism; Erectile Dysfunction
NCT00295620

Completed

Secondary Adjuvant Long Term Study With Arimidex

Conditions: Breast Cancer
NCT00094328

Completed

Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]

Conditions: Puberty, Precocious
NCT00078832

Active, not recruiting

Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer

Conditions: Breast Cancer
NCT00128843

Completed

Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer Patients

Conditions: Breast Cancer
NCT00887380

Active, not recruiting

STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing)

Conditions: Breast Cancer
NCT01953588

Active, not recruiting

Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery

Conditions: Estrogen Receptor-positive Breast Cancer; HER2-negative Breast Cancer; Invasive Ductal Breast Carcinoma; Invasive Lobular Breast Carcinoma; Recurrent Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer
NCT00323479

Completed

Arthralgia During Anastrozole Therapy for Breast Cancer

Conditions: Early Breast Cancer
NCT02137538

Unknown status

Aromatase Inhibitor Growth Study: Letrozole vs. Anastrozole

Conditions: Short Stature
NCT03966898

Not yet recruiting

A Study of SHR6390 in Combination With Letrozole or Anastrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer

Conditions: Advanced Breast Cancer
NCT01791985

Completed

AZD4547 & Anastrozole or Letrozole (NSAIs) in ER+ Breast Cancer Patients Who Have Progressed on NSAIs (RADICAL)

Conditions: Breast Cancer
NCT00921115

Active, not recruiting

Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.

Conditions: Invasive Breast Cancer
NCT00405938

Completed

Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer

Conditions: Breast Cancer; Breast Neoplasms
NCT00354640

Completed

Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer

Conditions: Breast Cancer
NCT01151215

Terminated

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

Conditions: Neoplasms; Breast Neoplasms; Breast Cancer
NCT00357110

Completed

Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer

Conditions: Breast Cancer
NCT01266213

Unknown status

Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women

Conditions: Metastatic Breast Cancer; Estrogen Receptor Positive Tumor; Breast Cancer Nos Premenopausal
NCT00256698

Completed

Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy

Conditions: Breast Cancer
NCT01234532

Terminated

Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by Surgery

Conditions: Estrogen Receptor-negative Breast Cancer; HER2-negative Breast Cancer; Progesterone Receptor-negative Breast Cancer; Stage I Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Triple-negative Breast Cancer
NCT00570323

Active, not recruiting

Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer

Conditions: Breast Cancer
NCT00186121

Completed

Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women

Conditions: Breast Cancer
NCT00936442

Completed

Arimidex Therapy Compliance Electronic Monitoring System

Conditions: Breast Cancer
NCT00555867

Terminated

Patient's Anastrozole Compliance to Therapy Programme

Conditions: Breast Cancer
NCT00637182

Completed

Gynecomastia Extension Study

Conditions: Gynecomastia